Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
EGFR
>>
Phase 1
«
1
2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
U3-1565
/ Daiichi Sankyo
Undisclosed EGFR/B7H3 CAR-T
/ Hedy Group, Guangzhou Medical University
WSD0922
/ Wayshine Biopharm
ZN-e4
/ Zentalis Pharma
[225Ac]-FPI-2068
/ AstraZeneca
anti-EGFRvIII CAR T cell therapy
/ Suzhou Maximum Bio-tech
cipatinib
/ Jiangsu Hengrui Pharma
etevritamab
(AMG 596) / Amgen
ficerafusp alfa
(BCA101) / Biocon
laprituximab emtansine
(IMGN289) / AbbVie
losatuxizumab vedotin
(ABBV-221) / AbbVie
serclutamab talirine
(ABBV-321) / AbbVie
tilatamig samrotecan
(AZD9592) / AstraZeneca
«
1
2
